Associate Director, Market Access HTA

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity
The Associate Director, Market Access HTA, Spain is responsible for defining and executing the market access strategy to ensure timely, sustainable patient access to innovative oncology therapies. Working closely with the Senior Director, Market Access HTA, in Spain, this role helps to shape business strategies, drives value demonstration, and leads engagement with key external stakeholders including payers, HTA bodies, and health authorities, both at national and regional level.

The incumbent will partner with regional and global commercial, HEOR, and medical affairs teams to deliver launch activities by providing access insights, developing evidence-based HTA, Pricing & Reimbursment dossiers and tools, engaging with market access and public affairs stakeholders as well as participating in pricing strategy activities, and drive the activities to deliver access results supporting the overall success of the product launches.

Responsibilities

Market Access & Reimbursement:
Develop and implement strategies to support access and pricing decisions for oncology products within the Spanish healthcare system

HTA & Pricing Filings:
Lead preparation and submission of value dossiers, and pricing negotiations with MoH and regional HTAs

Value Communication:
Translate clinical and economic evidence into compelling value communications tailored for Spanish payers.

External Stakeholder Engagement:
Build and maintain strong relationships with key external stakeholders (regional payers and policy maker authorities)

Identify and prioritize key stakeholders focus on HE with influence in HTAs process.

Effectively engages with HTA bodies and stakeholders like Regional HTAs, Physicians, Pharmacist and others identify as relevant.

Cross-Functional Collaboration:

Work with Global and EU Region Market Access teams to align local access strategy with broader European and corporate objectives, especially in terms of aligning the European regulatory and JCA strategy and execution with local value dossier submission and pricing negotiation strategies

Participation in negotiations with all levels of national and regional payers

Collaborate with internal functions to develop innovative pricing and value based contracting models to optimize the acceleration of reimbursement approvals

Policy Monitoring:
Monitor health policy developments, HTA processes and local reimbursement environments to inform strategy

Drive access and value related projects such as landscape assessments, payer market research, payer advidory boards and general guidance on local strategies

Development of outreach and engagement plan for key payers and their influencers creating and maintaining a strong network

Participate in early access planning of new products and indications, drive launch readiness for multiple oncology assets

Market Access in Field base Support:

Maintain an up-to-date understanding of customer perspectives through regular engagement with…